Navigation Links
HUYA Bioscience International Sponsors 'Best New Drug' Category at SCRIP Awards

SAN DIEGO, Dec. 3, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) was a proud sponsor of the 'Best New Drug' category at the 11th Annual SCRIP Awards. Dr. Mireille Gillings was a finalist for 'Executive of the Year' and HUYA was a finalist for 'Best Company in an Emerging Market'. These prestigious awards recognize excellence in the biopharmaceutical industry. HUYA CEO and Executive Chairman, Dr. Mireille Gillings, presented HUYA Bioscience's Best New Drug Award to Novartis which was recognized for the launch of its new product Cosentyx (secukinumab), a therapy for psoriasis. The award was presented at a ceremony at the Grosvenor House Hotel in London, attended by over 300 industry leaders.  

"Congratulations to Novartis on this recognition of excellence in pharmaceutical development," said Dr. Mireille Gillings, CEO of HUYA. "As we at HUYA are fully aware, launching innovative new products is the most important function of the industry. We are witnessing an exciting new era of drug development based on our ever deeper understanding of molecular medicine. This is generating improved pharmaceuticals with better safety and efficacy through molecular targeting. The next generation of therapies are going to have an enormous impact on public health, increased longevity and enhanced quality of life."

In this category, the judges were looking for the small-molecule or biological product that was approved in its first market worldwide during the qualifying period that represents the best therapeutic advance in its area. The recipient was selected by an 11-member, independent judging panel of senior industry experts from around the world.

In the 10 years since it was founded, HUYA has advanced the global development of novel oncology and cardiovascular drugs licensed from China. The company was the first to leverage the Tripartite Cooperation between China, Japan and South Korea to use clinical data from China to initiate drug development for HUYA's lead drug HBI-8000 in Japan for lymphoma. HUYA's drug has immunomodulatory properties which are important to the clinical development of immuno-oncology therapeutics.

About HUYA Bioscience International
HUYA is the leader in enabling and accelerating the global development of novel biopharmaceutical product opportunities originating in China. Extensive collaborations are established with Chinese biopharmaceutical, academic and commercial organizations to speed development and value creation in worldwide markets for China-sourced product candidates. With the largest Chinese compound portfolio covering all therapeutic areas, HUYA has emerged as the partner-of-choice for maximizing the value of biopharmaceutical innovation in China. HUYA has offices in the U.S., Japan, South Korea and eight strategic locations across China. With the largest team of scientists working with Chinese innovators, HUYA identifies and advances promising drug candidates globally. HUYA was awarded the Asia-Pacific Stevie® Award in the Health Products and Services & Pharmaceuticals category and a Gold Stevie Award in the Woman of the Year 2015 American Business Award category. For more information, please visit

About the SCRIP Awards
The SCRIP Awards provide the industry with an opportunity to acknowledge and applaud its highest achievers across all parts of the value chain, and to recognize both corporate and individual achievement.

Contact details:
Yiota Merianos
HUYA Corporate Communications

Photo -


SOURCE HUYA Bioscience International
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
2. The BioVoyage Institute is seeking the help of corporations, organizations, institutions, communities and individuals to help with bioscience and biotechnology education
3. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
4. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
5. Northstar Biosciences Launches All Natural Skincare Solutions
6. Blanchette Rockefeller Neurosciences Institute Partners with Neurotrope BioScience to Advance New Alzheimers Disease Discoveries
7. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
8. Seahorse Bioscience Announces AACR Travel Award Recipients
9. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
10. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
11. Nanotechnologies in Bioscience, Live Webinar on May 10
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... Charlotte, N.C. (PRWEB) , ... October 11, 2017 ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the ... Laboratories ( ASTER Labs ), Inc. has been selected for membership in ...
(Date:10/11/2017)... , ... October 11, 2017 , ... Personal eye wash is a basic first aid ... at a time. So which eye do you rinse first if a dangerous substance enters ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its dirt ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
Breaking Biology Technology:
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
Breaking Biology News(10 mins):